re: pfizer, sanofi-aventis and nektar therapeutics
well it looks like Nektar has beaten everyone to the punch - plus they have pfizer helping them through the regulatory minefield
EIF Price at posting:
0.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.